Key Points A randomized trial found better preservation of erectile function and bladder control with TULSA than with robotic prostate surgery at six months. Additional…
September 15, 2026
On World Lymphoma Awareness Day, a Spotlight on the Blood-Cancer Innovators in the PRISM Indexes
September 15 — World Lymphoma Awareness Day Every year on September 15, patient groups, clinicians, and researchers mark World Lymphoma Awareness Day to raise recognition…
Corbus Pharmaceuticals received FDA clearance to start its TEMPO‑1 registrational trial. Registrational studies are designed to provide the pivotal data needed to support a future…
July 28, 2026
Perspective Therapeutics Gains European Orphan Status for Targeted GEP‑NET Radiotherapy
Perspective Therapeutics (NYSE: CATX) received orphan medicinal product designation in Europe for its radiopharmaceutical candidate [212Pb]VMT‑α‑NET targeting gastroenteropancreatic neuroendocrine tumors (GEP‑NETs). Orphan status in the…
June 03, 2026
Women on Ozempic‑Like Drugs Saw Lower Breast Cancer Rates – What It Means for GLP‑1 Investors
A large Penn Medicine analysis found that women taking GLP‑1 drugs such as Ozempic and Wegovy from Novo Nordisk (NYSE: NVO), and Mounjaro or Zepbound…